10577575

Source:http://linkedlifedata.com/resource/pubmed/id/10577575

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0007194, umls-concept:C0009247, umls-concept:C0038952, umls-concept:C0087111, umls-concept:C0184511, umls-concept:C0231335, umls-concept:C0231491
pubmed:issue	6
pubmed:dateCreated	1999-12-10
pubmed:abstractText	The study analyzed factors, including treatment, affecting disease-related death in patients with hypertrophic cardiomyopathy (HCM) presenting in childhood.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8301365
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Calcium Channel Blockers, http://linkedlifedata.com/resource/pubmed/chemical/Propranolol, http://linkedlifedata.com/resource/pubmed/chemical/Verapamil
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	0735-1097
pubmed:author	pubmed-author:Ostman-SmithII, pubmed-author:RiesenfeldTT, pubmed-author:WettrellGG
pubmed:issnType	Print
pubmed:day	15
pubmed:volume	34
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1813-22
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:10577575-Adrenergic beta-Antagonists, pubmed-meshheading:10577575-Calcium Channel Blockers, pubmed-meshheading:10577575-Cardiomyopathy, Hypertrophic, pubmed-meshheading:10577575-Child, pubmed-meshheading:10577575-Cohort Studies, pubmed-meshheading:10577575-Humans, pubmed-meshheading:10577575-Noonan Syndrome, pubmed-meshheading:10577575-Propranolol, pubmed-meshheading:10577575-Risk Factors, pubmed-meshheading:10577575-Survival Analysis, pubmed-meshheading:10577575-Treatment Outcome, pubmed-meshheading:10577575-Verapamil
pubmed:year	1999
pubmed:articleTitle	A cohort study of childhood hypertrophic cardiomyopathy: improved survival following high-dose beta-adrenoceptor antagonist treatment.
pubmed:affiliation	Department of Pediatrics, John Radcliffe Hospital, Oxford, United Kingdom.
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't, Multicenter Study